Chemistry Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Chemistry Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$654K	Hold	3,436	–	–	0.1%	114
2026 Q1	$580K	Sell	3,436 -50	-1%	-$8.55K	0.1%	110
2025 Q4	$588K	Hold	3,486	–	–	0.11%	108
2025 Q3	$503K	Hold	3,486	–	–	0.1%	119
2025 Q2	$441K	Sell	3,486 -127	-4%	-$15.6K	0.09%	118
2025 Q1	$462K	Hold	3,613	–	–	0.11%	108
2024 Q4	$478K	Hold	3,613	–	–	0.11%	106
2024 Q3	$526K	Buy	3,613 +53	+1%	+$7.67K	0.12%	101
2024 Q2	$489K	Hold	3,560	–	–	0.13%	100
2024 Q1	$488K	Buy	3,560 +609	+21%	+$83.2K	0.13%	101
2023 Q4	$401K	Buy	2,951 +1	+0%	+$122	0.12%	106
2023 Q3	$361K	Hold	2,950	–	–	0.12%	106
2023 Q2	$375K	Hold	2,950	–	–	0.12%	111
2023 Q1	$381K	Buy	2,950 +52	+2%	+$6.81K	0.13%	106
2022 Q4	$381K	Buy	2,898 +5	+0.2%	+$646	0.15%	96
2022 Q3	$338K	Sell	2,893 -128	-4%	-$15.9K	0.13%	104
2022 Q2	$355K	Buy	3,021 +203	+7%	+$24.1K	0.14%	109
2022 Q1	$367K	Buy	+2,818	New	+$367K	0.13%	109

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Chemistry Wealth Management's IBB Position: Q2 2026 in Review

Chemistry Wealth Management held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 3,436 shares worth $654K. The position accounts for 0.1% of the portfolio, ranked #114.

Chemistry Wealth Management first reported a position in IBB in Q1 2022 and has held it in 18 quarters since. 958 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Chemistry Wealth Management held 3,436 shares of iShares Biotechnology ETF worth $654K as of Q2 2026.
Chemistry Wealth Management left its iShares Biotechnology ETF share count unchanged in Q2 2026.
iShares Biotechnology ETF made up 0.1% of Chemistry Wealth Management's portfolio in Q2 2026, its #114 holding.
Chemistry Wealth Management first reported a position in iShares Biotechnology ETF in Q1 2022 and has held it in 18 quarters since.
958 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Chemistry Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.